Jee Byung Chul, Suh Chang Suk, Kim Ki Chul, Lee Won Don, Kim Haeryoung, Kim Seok Hyun
Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, Korea.
Fertil Steril. 2009 Feb;91(2):528-34. doi: 10.1016/j.fertnstert.2007.11.081. Epub 2008 Mar 4.
To investigate temporal and spatial relationships of vascular endothelial growth factor (VEGF)-A and its receptor (VEGFR-1) expression in a luteal endometrium obtained from patients with repeated IVF failure.
Immunohistochemical study.
University hospital.
PATIENT(S): Thirty-three regular-cycling infertile women (mean age, 34.4 years) who experienced three or more failed IVF cycles (range, 3-14 cycles).
INTERVENTION(S): Endometrial samplings by silastic suction curette in the luteal phase of a spontaneous unmedicated cycle.
MAIN OUTCOME MEASURE(S): Immunohistochemical intensity scoring after staining by monoclonal anti-VEGF-A and polyclonal anti-VEGFR-1. Microvascular density determined after staining by monoclonal anti-CD31 antibody. The data were compared in three phases; early (cycle day [CD]16-19) (n = 12), mid- (CD20-24) (n = 13), and late luteal phase (CD25-27) (n = 8).
RESULT(S): Expression of VEGF-A tended to be lower in midluteal endometrium at epithelial, stromal, and endothelial cells. Expression of VEGFR-1 at epithelial cells was highest in midluteal endometrium, but VEGFR-1 at stroma and endothelium and microvascular density continuously decreased throughout luteal-phase endometrium.
CONCLUSION(S): In contrast to previous reports, VEGF-A expression was not highest in the midluteal phase in repeated IVF failure patients who had no apparent endometrial pathology. Further research is needed to determine whether different VEGF-A expression patterns in the luteal phase contribute to repeated IVF failure.
研究血管内皮生长因子(VEGF)-A及其受体(VEGFR)-1在反复体外受精失败患者黄体期子宫内膜中的时空关系。
免疫组织化学研究。
大学医院。
33名规律月经周期的不孕女性(平均年龄34.4岁),经历了3次或更多次体外受精周期失败(范围3 - 14个周期)。
在自然未用药周期的黄体期,用硅橡胶吸引刮宫器进行子宫内膜取样。
用单克隆抗VEGF - A和多克隆抗VEGFR - 1染色后的免疫组织化学强度评分。用单克隆抗CD31抗体染色后测定微血管密度。数据在三个阶段进行比较:早期(月经周期第[CD]16 - 19天)(n = 12)、中期(CD20 - 24天)(n = 13)和黄体晚期(CD25 - 27天)(n = 8)。
VEGF - A在上皮细胞、基质细胞和内皮细胞中的表达在黄体中期子宫内膜中趋于降低。VEGFR - 1在上皮细胞中的表达在黄体中期子宫内膜中最高,但在基质和内皮中的VEGFR - 1以及微血管密度在整个黄体期子宫内膜中持续下降。
与先前的报道相反,在没有明显子宫内膜病变的反复体外受精失败患者中,VEGF - A的表达在黄体中期并非最高。需要进一步研究来确定黄体期不同的VEGF - A表达模式是否导致反复体外受精失败。